APA (7th ed.) Citation

Kian, W., Christopoulos, P., Remilah, A. A., Levison, E., Dudnik, E., Shalata, W., . . . Roisman, L. C. (2022). Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer. Frontiers in oncology, 12, . https://doi.org/10.3389/fonc.2022.1010311

Chicago Style (17th ed.) Citation

Kian, Waleed, et al. "Real-world Efficacy and Safety of Mobocertinib in EGFR Exon 20 Insertion-mutated Lung Cancer." Frontiers in Oncology 12 (2022). https://doi.org/10.3389/fonc.2022.1010311.

MLA (9th ed.) Citation

Kian, Waleed, et al. "Real-world Efficacy and Safety of Mobocertinib in EGFR Exon 20 Insertion-mutated Lung Cancer." Frontiers in Oncology, vol. 12, 2022, https://doi.org/10.3389/fonc.2022.1010311.